Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aligos Therapeutics Inc. logo

Aligos Therapeutics Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

0.98
 
USD
  
0.00
  
(0.10%)
Optionable: Yes  Market Cap: 77 M  90-day average vol: 365,130

Previous close: 0.979  Open: 0.9501  Bid: 0.9303  Ask: 0.992
52 week range    
0.54   
   1.38
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 29th March 2024
50
MarketXLS Rank
60
Value
61
Technical
31
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ALGS Cash Flow

Annual
Invalid dateDec-20Dec-21Dec-22
(Increase) Decrease in other current assets-4 M-8 M6 M
(Increase) Decrease in other current liabilities12 M-5 M2 M
(Increase) Decrease in payables-130000.0-313000.02 M
CapitalExpenditureReported2 M892000.0943000.0
Cash at beginning of period70 M221 M187 M
Cash at end of period65 M187 M81 M
Cash flow-86 M-116 M-79 M
CashFlowFromContinuingInvestingActivities33 M3 M-26 M
ChangeInAccountPayable-130000.0-313000.02 M
ChangeInAccruedExpense10 M10 M-9 M
ChangeInInterestPayable10 M
ChangeInPayablesAndAccruedExpense9 M9 M-7 M
ChangeInWorkingCapital17 M-3 M545000.0
Depreciation3 M3 M2 M
Depreciation unreconciled4 M4 M4 M
DepreciationAndAmortization4 M4 M4 M
FinancingCashFlow48 M79 M164000.0
Free cash flow-88 M-117 M-80 M
GainLossOnInvestmentSecurities296000.0
Issuance of capital stock205000.0
IssuanceOfCapitalStock205000.0
IssuanceOfDebt-58000.0-79000.0-61000.0
Net cash from financing activities48 M-954000.0144000.0
Net cash from investing activities33 M3 M-26 M
Net cash from operating activities-86 M-116 M-79 M
Net change in cash & cash equivalents-5 M-34 M-106 M
Net income from continuing operations-109 M-128 M-96 M
NetCommonStockIssuance205000.0
NetInvestmentPropertiesPurchaseAndSale35 M4 M-25 M
NetInvestmentPurchaseAndSale35 M4 M-25 M
NetIssuancePaymentsOfDebt-58000.0-79000.0-61000.0
NetLongTermDebtIssuance-58000.0-79000.0-61000.0
NetPPEPurchaseAndSale-2 M-892000.0-943000.0
NetPreferredStockIssuance40 M
Operating (gains) losses296000.0
Other financing charges net7 M-875000.0
Other non-cash items2 M12 M13 M
PreferredStockIssuance40 M
ProceedsFromIssuanceOfWarrants1 M
ProceedsFromStockOptionExercised260000.0
Purchase of Float term investments-32 M-3 M-104 M
Purchase of property plant & equipment-2 M-892000.0-943000.0
PurchaseOfInvestment-45 M-19 M-104 M
PurchaseOfLongTermInvestments-13 M-16 M
PurchaseOfPPE-2 M-892000.0-943000.0
Repayment of debt-58000.0-79000.0-61000.0
RepaymentOfDebt-58000.0-79000.0-61000.0
Revenue per share824000.0845000.01 M
Sale of short term investments80 M23 M79 M
SaleOfInvestment80 M23 M79 M
StockBasedCompensation3 M13 M15 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University